Akoya prices $44M offering; terminates chief medical officer, HR head
gorodenkoff
Akoya Biosciences (NASDAQ:AKYA) has priced a $44M public offering and let go of its chief medical officer and chief people officer as part of a cost-cutting effort.
Akoya said in a statement that it had priced 8.7M shares priced at $5 apiece, which would raise close to $44M. Underwriters were granted an option to buy up to 1.3M additional shares at the offering price. Morgan Stanley and Piper Sandler are acting as joint bookrunners on the deal.
The biotech company also disclosed in an SEC filing that it had parted ways with its chief medical officer, Ehab El-Gabry, and chief people officer, Marilee Moy, as part of a cost savings initiative.
More on Akoya:
Akoya Biosciences, Inc. SEC Filing - Quarterly Report (10-Q) May 08, 2023